April 2013 Newsletter

April 11, 2013:

What’s in Store at the 2013 ASCRS Meeting

The 2013 meeting begins on April 19 in San Francisco. We preview some of the highlights.

April 11, 2013:

FDA Advisory Panel Recommends Approval of Trulign Toric Accommodating IOL

An FDA advisory panel put aside concerns about the definition of accommodation and recommended approval of the Bausch + Lomb Trulign Toric accommodating IOL.

April 11, 2013:

Bausch + Lomb Files IPO Signaling Plans to Return to Public Ownership

WP Prism, Inc., the company formed by Warburg Pincus and its associates to acquire Bausch + Lomb in 2007, filed a Form S-1 with the US Securities and Exchange Commission on March 22.

April 11, 2013:

April 2013 News Briefs

April 11, 2013:

Our Annual Cutout Page of Must-see Sessions at the ASCRS

Social media